Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/19138846

Bioorg. Med. Chem. Lett. 2009 Feb 15 19 4 1177-82

Download in:

View as

General Info

PMID
19138846